ADAM17 and glioblastoma: In this study, we found that GBM tumor cells released LRIG3 to a soluble form through the regulation of ADAM17 and attenuate the tilt towards an M2-dominant TAM population, thus remodelling the tumor microenvironment and suppressing tumor growth.